Concepedia

Rocco Serrao

RS

Statistics

Publications

3

Citations

198

H-Index

3

Active since

2019

Affiliations

Probity Medical Research(Current)

Rocco Serrao is an author at Probity Medical Research specializing in inflammatory skin disorders, dermatology, and immunotherapy.

Publications per year

2019–2025

3

Publications

3

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

, , +15

Long-Term Efficacy of Dupilumab in Alopecia Areata

Maansi Kulkarni, Craig A. Rohan, Jeffrey B. Travers et al. · American Journal of Case Reports · 2022 · 14 citations · Full text

, , +16

Efficacy and Safety of Once‐Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2–5 Years With Mild‐to‐Moderate Atopic Dermatitis ( <scp>INTEGUMENT</scp> ‐ <scp>PED</scp> ): A Phase 3 Randomized Controlled Trial

Lawrence F. Eichenfield, Rocco Serrao, Vimal H. Prajapati et al. · Pediatric Dermatology · 2025 · 12 citations · Full text

, , +17

1–3 of 3